Download PDFPDF

EPV105/#237 Combination targeted treatment with mek and pan-ERBB inhibitors enhances antitumor activity in erbb amplified ex-vivo serous endometrial cancer cells
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address